CClinicalTrials.gg
CompletedNCT03455010COMPUpdated Sep 18, 2019

Dose-Response Relationship of Ambulatory Load and Cartilage - Pilot Study

An interventional study of Increased load and Reduced load in Healthy, sponsored by University Hospital, Basel, Switzerland. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-18.

Sponsored by University Hospital, Basel, Switzerland · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The research question is if there is a dose-response relationship between blood biomarkers for articular cartilage and the magnitude of physiological load. To investigate this load induced biomarker change, the participants will complete a 30-minute walking test under three loading conditions: A: 80%, B: 100% C: 120% of their respective bodyweight (Fig. 1).

The main biomarker we are interested in is called cartilage oligomeric matrix protein (COMP). Serum COMP levels are increased immediately after 30-min running but there is no dose-response relationship shown yet.

Read the detailed description

The current state of research in the field and of our own research clearly shows that the in vivo mechanobiology of articular cartilage is poorly understood. Previous results of changes in cartilage biomarker concentrations after ambulatory exercise raise the following question:

Do load-induced changes in blood biomarkers for articular cartilage (COMP) depend on the physiological load magnitude? To generate initial data for answering this question, we will establish the experimental framework to systematically study the in vivo mechanobiology of human articular cartilage to address the following aims.

  • To obtain pilot data for investigating the in vivo dose-response relationship of weight-bearing and blood levels of mechanosensitive biomarker of articular cartilage using controlled load- bearing as experimental paradigm.
  • To provide pilot data for comparing ambulatory biomechanics between the controlled load- bearing conditions.

The experimental setting consists of a 30-minutes walking stress test under three loading conditions: A: 80 %, B: 100% and C: 120% bodyweight. Unloading will be achieved through an unloading system and additional loading with an adjustable weight vest. Before and after the walking stress test, venous blood samples will be taken at five time points. The biomarker concentration is measured with a commercial available enzyme-linked immunosorbent assay (ELISA).

Hypothesis Our working hypothesis is that there is a dose-response relationship between the temporarily increased or decreased load and the load-induced change in COMP level in the blood serum. We assume that serum COMP concentration increases with increasing accumulated load on the knee cartilage simulated through the three different loading conditions.

Design The design of the pilot study is a controlled multimodal data collection (biological, biomechanical) with block randomization. Specifically, we will collect blood samples and biomechanical (kinematic and pressure) data. We will determine the relationship between the serum blood concentration and the biomechanical data.

Because this is a cross-over study, all participants will perform the same three walking stress tests but in random order. Each participant of the study will be tested for 2.5 hours on 3 separate days.

Method In this experiment, we will test 24 healthy participants (12 male, 12 female) on 3 test days under three different loading conditions in a randomized block design. On each test day, participants will complete walking stress test for 30-minutes with A: 80%, B: 100% and C: 120% of their bodyweight. Through the modified bodyweight we generate higher or lower forces on the knee cartilage, which should affect the COMP concentration in the blood serum.

To measure the change in serum COMP concentration, blood samples will be taken at five time points before and after the walking stress test. The blood samples are taken by a study nurse. For the venipuncture, a thin, sterile, disposable vein catheter is placed in the antecubital vein. The catheter stays in the vein for the entire 2.5 hours of the experiment. Blood samples will be collected and allowed to clot for 30-minutes. Serum will be separated and frozen in aliquots to -20°C within 1 hour of collection and then transferred for storage at -80°C until assayed. Serum biomarker concentrations will be determined using commercial ELISAs.

02

Conditions studied

  • Healthy

Keywords

  • Ambulatory load
  • Biomarker
  • Articular cartilage
03

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age between 18 and 30 years
  • being physically active (> 2/week)
  • body mass index (BMI) \<30 kg/m2

Exclusion criteria

Exclusion Criteria:

  • previous knee injury
  • neuromuscular condition affecting gait
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • No intervention
    Normal load

    Healthy subjects walking for 30 minutes on a treadmill with normal body weight

  • Experimental
    Increased load

    Healthy subjects walking for 30 minutes on a treadmill with 20% additional body weight

    Other: Increased load

  • Experimental
    Reduced load

    Healthy subjects walking for 30 minutes on a treadmill with 20% lower body weight

    Other: Reduced load

Interventions

  • OtherIncreased load

    Participants walk with 120% body weight achieved with a weight vest

  • OtherReduced load

    Participants walk with 80% body weight achieved by a dynamic unloading system

05

What researchers measure

Primary outcomes

  1. Load-induced serum Cartilage Oligomeric Matrix Protein concentration

    Change in serum concentration during 30-minute walking exercise determined by commercial ELISA 30 min before to 2 hours after 30-minute walking exercise

    Time frame: 3 hours

Secondary outcomes

  1. Overall ground reaction force impulse

    Area under the ground reaction curve multiplied by number of steps taken during 30-minute walking exercise

    Time frame: 30 minutes

  2. Dynamic range of motion lower extremity joints

    Min to max joint angles (ankle, knee, hip) measured using RehaGait (inertial measurement units)

    Time frame: 30 minutes

Other outcomes

  1. Age

    Age in years

    Time frame: At enrollment

  2. Sex

    male or female

    Time frame: At enrollment

  3. Body mass index

    BMI in kg/m2

    Time frame: At enrollment

  4. Knee function

    Knee Osteoarthritis Outcome Score measured by questionnaire (best score: 100 - no limitations; worst score: 0)

    Time frame: At enrollment

06

Study locations

1 site
  • University Hospital Basel
    Basel, Basel Stadt 4031, Switzerland
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03455010
Lead sponsor
University Hospital, Basel, Switzerland
Collaborators
University of Erlangen-Nürnberg
Responsible party
Sponsor
First posted
Mar 6, 2018
Start date
Jul 5, 2017
Primary completion
Sep 30, 2017
Completion
Jul 31, 2019
Last update
Sep 18, 2019

Study contacts

Annegret Muendermann, PhD
principal investigator · University Hospital, Basel, Switzerland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion